Sharekhan

Entero Healthcare Solutions Ltd

Wed 11/06/2025,15:57:31 | NSE : ENTERO

₹ 1206.504.60 (0.38%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1208.00

Previous Close

₹ 1201.90

Volume

44291

Mkt Cap ( Rs. Cr)

₹5249.35

High

₹ 1217.90

Low

₹ 1192.00

52 Week High

₹ 1584.25

52 Week Low

₹ 1009.00

Book Value Per Share

₹ 386.78

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Entero Healthcare Solutions Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

1206.50

9

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

9

Option Chain

Analyzes market sentiment, predicts Entero Healthcare Solutions Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    4 Jun 2025, 7:20PM Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- Transcript of Earnings call
  • Entero Healthcare So - Copy of Newspaper Publication

    29 May 2025, 6:26PM Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    28 May 2025, 6:56PM Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording of Earning call on Audited Financial Results for the quarter and
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    28 May 2025, 6:48PM Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Recording of Earnings Call/ Conferenc
  • Entero Healthcare So - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    28 May 2025, 5:40PM Entero Healthcare Solutions Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
  • Entero Healthcare So - Acquisition-XBRL

    28 May 2025, 2:28AM ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange regarding Acquisition
  • Entero Healthcare So - Acquisition-XBRL

    28 May 2025, 2:27AM ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange regarding Acquisition
  • Entero Healthcare So - Acquisition-XBRL

    28 May 2025, 2:26AM ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange regarding Acquisition
  • Entero Healthcare So - Acquisition-XBRL

    28 May 2025, 2:25AM ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange regarding Acquisition
  • Entero Healthcare So - Acquisition-XBRL

    28 May 2025, 2:23AM ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange regarding Acquisition
  • Entero Healthcare So - Acquisition-XBRL

    28 May 2025, 2:22AM ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange regarding Acquisition
  • Entero Healthcare So - Acquisition-XBRL

    28 May 2025, 2:20AM Entero Healthcare Solutions Limited has informed the Exchange regarding Acquisition
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Investor Presentation

    27 May 2025, 10:54PM Investor presentation on Audited Financial Results of the Company for the quarter and year ended March 31, 2025.
  • Entero Healthcare So - Investor Presentation

    27 May 2025, 10:51PM Entero Healthcare Solutions Limited has informed the Exchange about Investor Presentation
  • Entero Healthcare So - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    27 May 2025, 10:25PM ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share
  • Entero Healthcare So - Change In Designation Of Mr. Kevin Daftary From Non Executive Non Independent Director To Nominee Dire

    27 May 2025, 10:12PM Change in designation of Mr. Kevin Daftary from Non Executive Non Independent Director to Nominee Director.
  • Entero Healthcare So - Change in Director(s)

    27 May 2025, 10:04PM Entero Healthcare Solutions Limited has informed the Exchange regarding Change in Director(s) of the company.
  • Entero Healthcare So - Appointment Of M/S. BNP & Associates, Practicing Company Secretaries (Firm Registration No. P2014MH037

    27 May 2025, 9:56PM Appointment of Secretarial Auditor of the Company.
  • Entero Healthcare So - Change in Auditors

    27 May 2025, 9:45PM Entero Healthcare Solutions Limited has informed the Exchange regarding Change in Auditors of the company.
  • Entero Healthcare So - Allotment of Securities

    27 May 2025, 9:16PM Entero Healthcare Solutions Limited has informed the Exchange regarding allotment of 1200 securities pursuant to ESOP/ESPS at its meeting held on May
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    27 May 2025, 9:13PM Allotment of 1200 Equity shares of Rs. 10/- each to the eligible employees of the Company, upon exercise of options vested under the Entero Employee S
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Acquisition

    27 May 2025, 9:02PM Intimation regarding proposed acquisitions.
  • Entero Healthcare So - Acquisition

    27 May 2025, 9:02PM Entero Healthcare Solutions Limited has informed the Exchange about Acquisition
  • Entero Healthcare So - General Updates

    27 May 2025, 7:55PM Entero Healthcare Solutions Limited has informed the Exchange about General Updates on Change in Authorizaton of Key Managerial Personnel ( KMP ) for
  • Entero Healthcare So posts Q4 net loss of Rs 27.81 cr

    27 May 2025, 7:45PM The company reported standalone net loss during the quarter stood at Rs 27.81 crore compared to net profit of Rs 37.28 crore in the previous year quar
  • Entero Healthcare So - Results - Audited Financial Results For Quarter And Year Ended March 31, 2025.

    27 May 2025, 7:29PM Submission of Audited Financial results for quarter and year ended March 31, 2025.
  • Entero Healthcare So - Outcome of Board Meeting

    27 May 2025, 7:22PM Submission of Audited Financial Results for the quarter and year ended March 31, 2025
  • Entero Healthcare So - Board Meeting Outcome for Outcome Of Board Meeting Held On May 27, 2025

    27 May 2025, 6:56PM Outcome of Board meeting held on May 27, 2025 inter-alia for approval of financial results for quarter and year ended March 31, 2025.
  • Entero Healthcare So - Outcome of Board Meeting

    27 May 2025, 6:54PM Entero Healthcare Solutions Limited has informed the Exchange regarding Board meeting held on May 27, 2025.
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    23 May 2025, 11:20AM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of Earnings call on Audited Financial Results of the Company for the Quar
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 May 2025, 11:13AM Intimation of Earnings call on Audited Financial Results of the Company for the Quarter and Year ended March 31, 2025.
  • Entero Healthcare So - General Updates

    22 May 2025, 3:36PM Entero Healthcare Solutions Limited has informed the Exchange about General Updates
  • Entero Healthcare So - Update- Submission Of Resignation Letter Of Director

    22 May 2025, 3:23PM Submission of Resignation letter
  • Entero Healthcare So - Board Meeting Intimation

    21 May 2025, 4:18PM Entero Healthcare Solutions Limited has informed the Exchange about Board Meeting to be held on 27-May-2025 to inter-alia consider and approve the Aud
  • Entero Healthcare So - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended Marc

    21 May 2025, 1:18PM Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to c
  • Entero Healthcare So - Disclosure under SEBI Takeover Regulations

    15 May 2025, 5:23PM OrbiMed Asia III Mauritius Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of I
  • Entero Healthcare So - Submission Of Monitoring Agency Report For The Quarter Ended March 31, 2025

    9 May 2025, 12:26PM Submission of Monitoring Agency Report for the quarter ended March 31, 2025.
  • Entero Healthcare So - Monitoring Agency Report

    9 May 2025, 12:25PM Monitoring Agency Report issued by the ICRA Limited for the quarter ended March 31, 2025
  • Entero Healthcare So - Disclosure under SEBI Takeover Regulations

    8 May 2025, 4:50PM Prabhat Agrawal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial A
  • Entero Healthcare So - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    28 Apr 2025, 7:12PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Entero Healthcare So - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    22 Apr 2025, 9:28PM Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Entero Healthcare So has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    15 Apr 2025, 7:00AM As of March 2025, 52.42% is owned by Promoters and 47.58% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 14.41% and Fore
  • Entero Healthcare So - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Apr 2025, 12:27PM Certificate under Regulation 74(5) of Securities and Exchange Board of India(Depositories and Participants) Regulations, 2018 for the Quarter ended Ma
  • Entero Healthcare So - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 12:28PM Certificate under Regulation 74(5) of SEBI (Depositories and Participant) Regulation, 2018 for the quarter ended March 31, 2025.
  • Entero Healthcare So - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    1 Apr 2025, 3:12PM Entero Healthcare Solutions Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    28 Mar 2025, 8:27PM Update on intimation on acquisition of balance equity shares in Getwell Medicare Solution Private Limited to make it wholly owned subsidiary Company.
  • Entero Healthcare So - Acquisition

    28 Mar 2025, 8:27PM Entero Healthcare Solutions Limited has informed the Exchange about Updating on acquisition of balance equity shares in Getwell Medicare Solution Priv
  • Entero Healthcare So - Trading Window

    24 Mar 2025, 8:11PM Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) R
  • Entero Healthcare So - Trading Window-XBRL

    24 Mar 2025, 8:07PM Entero Healthcare Solutions Limited has informed the Exchange about Closure of Trading Window
  • Entero Healthcare So - Sale or disposal-XBRL

    24 Mar 2025, 10:24AM Entero Healthcare Solutions Limited has informed the Exchange regarding Sale or disposal of unit(s)/division(s)/subsidiary
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Change in Management

    21 Mar 2025, 2:49PM Resignation and appointment of Chief Financial Officer
  • Entero Healthcare So - Change in Management

    21 Mar 2025, 2:48PM Entero Healthcare Solutions Limited has informed the Exchange about change in Management
  • Entero Healthcare So - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    21 Mar 2025, 2:37PM ENTERO HEALTHCARE SOLUTIONS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share
  • Entero Healthcare So - Board Meeting Outcome for Outcome Of Board Meeting Held On March 21, 2025

    21 Mar 2025, 2:27PM Outcome of Board Meeting held on March 21, 2025
  • Entero Healthcare So - Outcome of Board Meeting

    21 Mar 2025, 2:25PM Entero Healthcare Solutions Limited has informed the Exchange regarding Outcome of Board Meeting held on March 21, 2025.
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Mar 2025, 9:12PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of Investor meet to be held on March 26, 2025
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    19 Mar 2025, 9:07PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on March 26, 2025 at 12:00 Noon (IST)
  • Entero Healthcare So - Press Release

    19 Mar 2025, 11:17AM Entero Healthcare Solutions Limited has informed the Exchange regarding a press release dated March 19, 2025, titled ""Entero launches HealthEdge pr
  • Entero Healthcare So - Press Release

    19 Mar 2025, 10:37AM Entero Healthcare Solutions Limited has informed the Exchange regarding a press release dated March 19, 2025, titled ""Entero launches HealthEdge pr
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 Mar 2025, 10:37AM Submission of information pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015- Media Release/Press Rel

Key fundamentals

Evaluate the intrinsic value of Entero Healthcare Solutions Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1650.38 1626.414 675.232 581.205 486.4381
Liabilities 1650.38 1626.414 675.232 581.205 486.4381
Equity 43.508 43.494 4.112 3.85 0.1002
Gross Profit -30.346 -34.494 -43.916 -53.716 -36.9478
Net Profit 19.181 38.44 -12.455 -40.847 -18.1512
Cash From Operating Activities -109.016 -75.65 -56.909 -44.698 -68.1958
NPM(%) 4.69 12.08 -7 -29.75 -18.17
Revenue 408.67 318.161 177.69 137.286 99.8955
Expenses 439.016 352.655 221.606 191.002 136.8433
ROE(%) 1.13 2.28 -0.74 -2.42 -1.07

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Entero Healthcare Solutions Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 855.40 0.52 28.38 686.29 301.39 0.58
Lotus Eye Hospital and Institute Ltd 72.06 -1.95 205.89 2500.75 3.55 0.00
Vaishali Pharma Ltd 12.58 -2.25 209.67 1288.98 3.13 0.00
Astec Lifesciences Ltd 808.70 -0.33 0.00 2358.00 -687.10 0.00

Company Info

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Read More

Parent Organisation

Entero Healthcare Solutions Ltd.

Founded

10/01/2018

Managing Director

Mr.Prabhat Agrawal

NSE Symbol

ENTEROEQ

FAQ

The current price of Entero Healthcare Solutions Ltd is ₹ 1206.50.

The 52-week high for Entero Healthcare Solutions Ltd is ₹ 1217.90 and the 52-week low is ₹ 1192.00.

The market capitalization of Entero Healthcare Solutions Ltd is currently ₹ 5249.35. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Entero Healthcare Solutions Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Entero Healthcare Solutions Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Entero Healthcare Solutions Ltd shares.

The CEO of Entero Healthcare Solutions Ltd is Mr.Prabhat Agrawal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT